Features of the Metabolic Syndrome after Childhood Craniopharyngioma
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Obesity and multiple pituitary hormone deficiency are common complications after surgery for childhood craniopharyngioma. We hypothesized that post craniopharyngioma surgery, children are at high risk for the metabolic syndrome, including insulin resistance due to excess weight gain and GH deficiency. This study characterized body composition (anthropometry and dual energy x-ray absorptiometry) and metabolic outcomes in 15 children (10 males and 5 females; age, 12.2 yr; range, 7.2-18.5 yr) after surgical removal of craniopharyngioma. In 9 subjects, outcomes were compared with those of healthy age-, sex-, body mass index-, and pubertal stage-matched controls. Insulin sensitivity was measured by 40-min iv glucose tolerance test. Seventy-three percent of subjects were overweight or obese. Sixty-six percent had normal growth velocity without GH treatment. Subjects had increased abdominal adiposity (P = 0.008) compared with controls. However, there was no significant difference in total body fat. Subjects had higher fasting triglycerides (P = 0.02) and lower high density lipoprotein cholesterol to total cholesterol ratio (P = 0.015). Insulin sensitivity was equally reduced for subjects and controls (P = 0.86). After craniopharyngioma removal, patients had more features of the metabolic syndrome compared with controls. This could be a result of hypothalamic damage causing obesity and GH deficiency. Further studies exploring predictors of the metabolic syndrome after craniopharyngioma surgery are required.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hypopituitarism, in general, and GHD, in particular, are associated with a number of metabolic alterations (74 -79).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [76]
In the citing paper
“Altered body composition, insulin resistance, hypertension, unfavorable lipid profile, endothelial dysfunction and atherosclerosis have been found in several studies on patients with long-term GHD (74,76,77,(82)(83)(84)(85)(86)(87).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [76]
In the citing paper
“Childhood survivors of craniopharyngioma (64), the prototypic tumor causing hypothalamic syndrome, have elevated cardiovascular disease risk factors that portend future excess rates of premature mortality (65).”
From Approach to the patient with acquired hypothalamic syndrome (2026) · cites this paper as [64]
Citations
Cites
Tanner, J. M., & Whitehouse, R. H. (1976) · Archives of Disease in Childhood · doi:10.1136/adc.51.3.170 · Cited by 3,137
Physical growth: National Center for Health Statistics percentiles
Hamill, P. V. V., Drizd, T., Johnson, C., Reed, R., Roche, A., & Moore, W. (1979) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/32.3.607 · Cited by 2,323
Premature mortality due to cardiovascular disease in hypopituitarism
Rosén, T., & Bengtsson, B.-Å. (1990) · The Lancet · doi:10.1016/0140-6736(90)91812-o · Cited by 1,402
Aggressive surgical management of craniopharyngiomas in children
Hoffman, H. J., Silva, M. D., Humphreys, R. P., Drake, J. M., Smith, M. L., & Blaser, S. I. (1992) · Journal of Neurosurgery · doi:10.3171/jns.1992.76.1.0047 · Cited by 567
Mucinous carcinoma of the colon and rectum
Symonds, D. A., & Vickery, A. L. (1976) · Cancer · doi:10.1002/1097-0142(197604)37:4<1782::aid-cncr2820370424>3.0.co;2-f · Cited by 383
WELCH, S., GEBHART, S. S. P., BERGMAN, R. N., & PHILLIPS, L. S. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-6-1508 · Cited by 337
Growth hormone-deficient adults are insulin-resistant
Johansson, J.-O., Fowelin, J., Landin, K., Lager, I., & Bengtsson, B.-Å. (1995) · Metabolism · doi:10.1016/0026-0495(95)90004-7 · Cited by 275
Müller, H. L., Bueb, K., Bartels, U., Roth, C., Harz, K., Graf, N., Korinthenberg, R., Bettendorf, M., Kühl, J., Gutjahr, P., et al. (2001) · Klinische Pädiatrie · doi:10.1055/s-2001-16855 · Cited by 273
Craniopharyngiomas. A clinical and pathological review
Petito, C. K., Degirolami, U., & Earle, K. M. (1976) · Cancer · doi:10.1002/1097-0142(197604)37:4<1944::aid-cncr2820370446>3.0.co;2-# · Cited by 267
Gotherstrom, G. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.10.4657 · Cited by 228
Body-composition assessment by dual-energy x-ray absorptiometry in subjects aged 4-26 y
Ogle, G., Allen, Jr., Humphries, I., Lu, P., Briody, J., Morley, K., Howman-Giles, R., & Cowell, C. (1995) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/61.4.746 · Cited by 205
Self-citationImportance of lean mass in the interpretation of total body densitometry in children and adolescents
Högler, W., Briody, J., Woodhead, H. J., Chan, A., & Cowell, C. T. (2003) · The Journal of Pediatrics · doi:10.1016/s0022-3476(03)00187-2 · Cited by 177
Self-citationHew, F. L. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.2.555 · Cited by 169
Co-existence of severe insulin resistance and hyperinsulinaemia in pre-adolescent obese children
Caprio, S., Bronson, M. L., Sherwin, R. S., Rife, F., & Tamborlane, W. V. (1996) · Diabetologia · doi:10.1007/s001250050603 · Cited by 123
Abdominal fat and birth size in healthy prepubertal children
Garnett, S. P., Cowell, C., Baur, L. A., Fay, R., Lee, J., Coakley, J. C., PEAT, J. K., & Boulton, T. (2001) · International Journal of Obesity · doi:10.1038/sj.ijo.0801821 · Cited by 117
Self-citationGrowth hormone and the metabolic syndrome.
Johannsson, G., & Bengtsson, B. Å. (1999) · PubMed · Cited by 113
Koranyi, J. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.10.4693 · Cited by 112
Galvin, P., Ward, G., Walters, J., Pestell, R., Koschmann, M., Vaag, A., Martin, I., Best, J. D., & Alford, F. (1992) · Diabetic Medicine · doi:10.1111/j.1464-5491.1992.tb01732.x · Cited by 112
THE GROWTH WITHOUT GROWTH HORMONE SYNDROME
Geffner, M. E. (1996) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70345-5 · Cited by 108
Hwu, C.-M., Kwok, C. F., Lai, T.-Y., Shih, K.-C., Lee, T.-S., Hsiao, L.-C., Lee, S.-H., Fang, V. S., & Ho, L.-T. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.10.4311 · Cited by 105
BOUGNERES, P.-F., ARTAVIA-LORIA, E., FERRE, P., CHAUSSAIN, J.-L., & JOB, J.-C. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-61-6-1152 · Cited by 95
Growth hormone in the regulation of hyperlipidemia
Blackett, P. R., WEECH, P. K., McConathy, W. J., & Fesmire, J. D. (1982) · Metabolism · doi:10.1016/0026-0495(82)90121-4 · Cited by 81
Roemmich, J. N., Huerta, M. G., Sundaresan, S. M., & Rogol, A. D. (2001) · Metabolism · doi:10.1053/meta.2001.22510 · Cited by 74
Craniopharyngioma: Endocrine Sequelae of Treatment
Sklar, C. A. (1994) · Pediatric Neurosurgery · doi:10.1159/000120873 · Cited by 74
Serum cholesterol and triglycerides in children with growth hormone deficiency
Winter, R. J., Thompson, R. G., & Green, O. C. (1979) · Metabolism · doi:10.1016/0026-0495(79)90138-0 · Cited by 60
Increased insulin sensitivity in young, growth hormone deficient children
Husbands, S., Ong, K. K., Gilbert, J., Wass, J. A. H., & Dunger, D. B. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01298.x · Cited by 37
Beneficial effect of growth hormone on atherogenic risk in children with growth hormone deficiency
Kohno, H., Ueyama, N., Yanai, S., Ukaji, K., & Honda, S. (1995) · The Journal of Pediatrics · doi:10.1016/s0022-3476(95)70220-2 · Cited by 36
Body composition, atherogenic risk factors and apolipoproteins following growth hormone treatment
Hassan, H. M., Kohno, H., Kuromaru, R., Honda, S., & Ueda, K. (1996) · Acta Paediatrica · doi:10.1111/j.1651-2227.1996.tb14180.x · Cited by 32
Lipids and apolipoproteins in growth hormone-deficient children during treatment
Schaefer, G. B., Greger, N. G., Fesmire, J., Blackett, P. R., Wilson, D. P., & Frindik, J. P. (1994) · Metabolism · doi:10.1016/0026-0495(94)90001-9 · Cited by 32
Hypopituitarsim Is Associated with Triglyceride Enrichment of Very Low-Density Lipoprotein
Kearney, T., de Gallegos, C. N., Chrisoulidou, A., Gray, R., Bannister, P. A., Venkatesan, S., & Johnston, D. G. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.8.7774 · Cited by 16
Kuromaru, R., Kohno, H., & Hara, T. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01527.x · Cited by 12
Cited by
Karavitaki, N., Cudlip, S., Adams, C. B. T., & Wass, J. A. H. (2006) · Endocrine Reviews · doi:10.1210/er.2006-0002 · Cited by 514
Müller, H. L. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1115 · Cited by 401
“Obesity and eating disorders result in increased risks of metabolic syndrome (195) and cardiovascular disease (203), including sudden death events (209), increased multisystem morbidity (189), and increased mortality (108, 186, 210 –216).”
Mortality in Patients with Pituitary Disease
Sherlock, M., Ayuk, J., Tomlinson, J. W., Toogood, A. A., Aragon-Alonso, A., Sheppard, M. C., Bates, A. S., & Stewart, P. M. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0033 · Cited by 392
“Posttreatment pituitary dysfunction in radiotherapy series (reflecting data from patients receiving surgery plus radiotherapy and radiotherapy only) ranges from 91 to 100% (232, 233, 237, 246, 254, 273) and panhypopituitarism from 80 to 100% (232, 235, 237, 254, 260).”
BackgroundSterkenburg, A. S., Hoffmann, A., Gebhardt, U., Warmuth-Metz, M., Daubenbüchel, A. M. M., & Müller, H. L. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov044 · Cited by 248
“Obesity—regardless of origin—results in an increased risk of metabolic syndrome and cardiovascular disease.(38,40) The previously mentioned CP with HI outcomes of diminished physical functioning, as well as dyspnea, are conceivable comorbidities described in metabolic syndrome.”
BackgroundPereira, A. M., Schmid, E. M., Schutte, P. J., Voormolen, J. H. C., Biermasz, N. R., Van Thiel, S. W., Corssmit, E. P. M., Smit, J. W. A., Roelfsema, F., & Romijn, J. A. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02196.x · Cited by 220
Metadata
- Authors
- Srinivasan, S., Ogle, G. D., Garnett, S. P., Briody, J. N., Lee, J. W., & Cowell, C. T.
- Affiliations
- Children's Hospital at Westmead (AU)
- Corresponding author
- Srinivasan, S.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2004-01
- Volume
- 89
- Issue
- 1
- Pages
- 81-86
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2076437294
- Semantic Scholar
- f7542c257f39f2cc67239e5e9c8a71bcb1741981
- Cited by
- 211
- References
- 30
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 5 · 2023: 8 · 2022: 8 · 2021: 6 · 2020: 12 · 2019: 1 · 2018: 9 · 2017: 9 · 2016: 13 · 2015: 16 · 2014: 12 · 2013: 14 · 2012: 5
- FWCI
- 5.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Keywords
- metabolic syndrome, childhood craniopharyngioma, postoperative complications, obesity, insulin resistance, growth hormone deficiency, multiple pituitary hormone deficiency, abdominal fat, body composition, lipid profile, hypothalamic injury
- MeSH terms
- Abdomen, Adipose Tissue, Adolescent, Blood Glucose, Body Composition, Child, Cholesterol, Craniopharyngioma, Fasting, Female, Glucose Tolerance Test, Humans, Insulin, Insulin Resistance, Insulin-Like Growth Factor I, Cholesterol, HDL, Male, Obesity, Pituitary Neoplasms, Postoperative Complications, Triglycerides, Body Mass Index, Human Growth Hormone, Leptin, Metabolic Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.